Skip to main content
OpenTrials
Completed

NCT Number: NCT05048173

Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer

To compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage endometrial cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Early Stage Endometrial Cancer Lymphadenectomy Sentinel Lymph Nodes

Age range

20 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

About this study

This retrospective study aims to compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage endometrial cancer by reviewing the medical records.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≧ 20 years
  • early stage endometrial cancer (FIGO stage I)

Exclusion criteria

  • Did not receive a complete course of treatment in this hospital, interrupted the treatment halfway (except if the disease continued to deteriorate or caused death during treatment), and did not follow up in this hospital after the course of treatment.

Treatment and study plan

Sentinel Lymph Node Mapping and Biopsy

Procedure

Sentinel lymph node mapping with indocyanine green dye followed by biopsy if positive

Lymphadenectomy

Procedure

Conventional lymphadenectomy

Primary outcomes

  1. progression free survival

    Time frame: 4 years

    The length of time from the day of operation till recurrence or last follow up

  2. overall survival

    Time frame: 4 years

    The length of time from the day of operation till death (of any cause) or last follow up

Secondary outcomes

  1. surgical complications related to lymph node biopsy or lymphadenectomy

    Time frame: from the day of operation till post-operative 6 months

    asymptomatic lymphocele, lymphedema, infected lymphocele

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Official study title

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early Stage Endometrial Cancer

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Sep 17, 2021
Registry last updated
Sep 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.